💊 US FDA approvals galore; An end for many partnerships; Thinking about India’s Union budget
Welcome to February 2022.
Today’s issue is brought to you by AI + ML. Or is it?Â
Welcome to February 2022.
Today’s issue is brought to you by AI + ML. Or is it?Â